As part of the Target Safely initiative, the American Society for Radiation Oncology (ASTRO) has developed a white paper, the first of a series of such papers, on the safe use of integrating intensity modulated radiation therapy (IMRT) into the radiation oncology clinic. The executive summary of this white paper is published in the July print issue of Practical Radiation Oncology (PRO), ASTRO's clinical practice journal.
Radiation therapy has been used safely and effectively for more than 100 years to treat cancer. In the past few decades, researchers have created new techniques for delivering radiation that further target the tumor while sparing nearby healthy tissue, thus improving the chances of a cure while minimizing side effects. One such technique is called intensity modulated radiation therapy or IMRT.
IMRT is a tremendous advance in the safe and effective delivery of radiation. However, it also requires much more time and resources from cancer clinics, radiation oncologists, physicists, radiation therapists, dosimetrists, nurses and their support staff to be done correctly.
Errors in radiation therapy are extremely rare, but ASTRO's leadership knows that even one error, however minor, is too many. That's why ASTRO began the Target Safely initiative to help the radiation oncology community further prevent treatment delivery mistakes.
The main concerns raised in this white paper are:
The report also provides practical guidance that radiation oncology treatment teams can use in their clinics to improve safety. This guidance includes identifying the key components of an IMRT system, an example of the roles and responsibilities within the IMRT planning and delivery process, a list of examples of possible problems that may occur within the process along with possible remedial actions, and a list of recommendations to guard against catastrophic failures for IMRT.
"Intensity modulated radiation therapy has been a tremendous advance in the way we treat patients by improving the planning and delivery of radiation therapy. IMRT and other advances in radiation therapy can be used to deliver high doses to tumors while decreasing the dose to healthy tissues," Jean M. Moran, PhD, lead author of the study, Associate Professor and the Associate Division Director for Clinical Physics at the University of Michigan Medical Center in Ann Arbor, Mich., said. "IMRT is, however, incredibly time and resource intensive. It involves the use of sophisticated software and delivery systems and many hand-offs between team members throughout the simulation, planning, and delivery process. It is our hope that practitioners will use the tools and techniques presented in this document to reassess and strengthen their own IMRT programs."
Cite This Page: